Connect with us


Silicon Valley’s Secret $1 Pot Stock: Bill Poulos Cannabis Investing Profits Run




Silicon Valley’s Secret $1 Pot Stock is a video demonstration that tells consumers about a new stock that they should investment in before it becomes much more expensive. Consumers must purchase a subscription to the creator’s investment newsletter to access the guide on this pot stock.

What is Silicon Valley’s Secret $1 Pot Stock?

The cannabis industry is picking up, as more states and countries adopt regulations that permit the use of this product. Over 30 states have already legalized marijuana at some level. As a result, companies are starting to be allowed to be publicly traded as “pot stocks.” There are many different promotions online that allow consumers to learn about some of the best investments they can make in the market, like Silicon Valley’s Secret $1 Pot Stock.

Silicon Valley’s Secret $1 Pot Stock opens their presentation by telling consumers that there’s a pot stock that is presently trading for a dollar that could help them get in early on this growing industry. The creator of the program – Bill Poulos – discusses the way that this stock is following the path that Apple and its founder Steve Jobs took in the investment world, suggesting that it may soon be just as lucrative as the technology company turned out to be.

Poulos states that the only way that massive growth will be seen by this industry is in the legalization of marijuana. He explains that cannabis stock sells their product to the consumers, and it presently is in the works to become one of the largest producers of cannabis in North America. The stock allegedly has:

  • 40 licensed medical clinics
  • 78 unique medicinal cannabis products
  • 138,000 kg of annual production capacity

Continuing to tie the progress of this medical marijuana company to Apple, he added the “Perfect Marijuana Stock” is in charge of the production, distribution, and the final sale of this product. However, the same can be said of any company producing their own marijuana or hemp stock. Still, Poulos states that the only way to see success in the marijuana industry is to “own a stock that has something all the other marijuana stocks don’t.”

The Perfect Marijuana Stock is relatively unknown, but the author of this guide states that it is “the only unique, vertically integrated medicinal marijuana company in the world.” Again, he reiterates that the success of this company is due to following nearly the same path as Apple, and he expresses that he feels lucky to have discovered it.

To get all of the benefits advertised, Poulos predicts that the industry is mere months away from seeing this stock bring in significant gains, considering a recent (yet unnamed) acquisition. He said that there are two reasons that the stock will flourish:

  1. Increased demand for medical marijuana.
  2. New products fueled by cutting-edge research and development.

The medical marijuana sector is set to have major growth soon, according to the creator of this program. He even brings up a Bible verse (Genesis 9:3) to support the goodness that marijuana has – “Every moving thing that lives shall be food for you. As I give you green plants, I give you everything.” He adds that hemp is mentioned in the Bible frequently, which is why he, as a Christian man, has no qualms with investing in the industry.

Accessing “The Perfect Marijuana Stock”

The success of this company is centered around selling less marijuana to create more demand. However, before consumers can learn more about the technique, they have to agree to receive the guide titled “The Perfect Marijuana Stock,” which is available for free today, but the consumer has to pay for a trial membership of The Premium Income Letter, a newsletter on investments by Poulos.

The membership is available for nearly $200 typically, but the advertisement shows that it is available for $49. Poulos asks the buyer to recruit friends to purchase the membership to gain the discount.

Contacting The Creators Of Silicon Valley’s Secret $1 Pot Stock

Even with the information provided online, consumers may have questions about this program. Consumers can “submit a ticket” for review, which is done by sending an email to


Much of the advertisement for this pot stock and the guide focus on the path that Apple has taken and the connections between these opportunities. The only way to access the materials, or even the name of the pot stock, is to purchase the e-guide advertised at the end of the video.

The creator even states that the “perfect” stock he’s toting won’t be found in the portfolios of investment banks or hedge funds. Therefore, it is up to the consumer to decide if this product can help them spend less at the beginning to profit more later, or if the product is set up to fail.

Arina has a Master’s degree in Business and lives in Sydney, Australia and is one of our top contributors as a postgraduate qualified writer. While being a Member Of The Appraisal Institute, she focuses her writing efforts on health, home, business, technology and now cannabis/cbd here.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.